Section 689.704 – Preexposure and post-exposure antiretroviral therapies; HIV tests; rules.
(1) As used in this section: (a) “HIV test” has the meaning given that term in ORS 433.045. (b) “Post-exposure prophylactic antiretroviral therapy” means a drug or other therapy intended to reduce the likelihood of the acquisition of human immunodeficiency virus following a possible exposure to human immunodeficiency virus. (c) “Preexposure prophylactic antiretroviral therapy” means […]
Section 689.735
[1955 c.326 §7; 1969 c.514 §22; renumbered 689.810]
Section 689.740
[1955 c.326 §8; 1969 c.514 §23; renumbered 689.815]
Section 689.765
[1979 c.777 §39; 1985 c.131 §6; 1987 c.108 §8; 1987 c.736 §2; 1993 c.571 §19; 2003 c.103 §3; 2005 c.462 §9; 2008 c.4 §4; 2009 c.326 §6; renumbered 689.527 in 2009]
Section 689.681 – Opiate overdose; treatments; administration of naloxone; rules.
(1) As used in this section: (a) “Kit” means a dose of naloxone and the necessary medical supplies to administer the naloxone. (b) “Opiate” means a narcotic drug that contains: (A) Opium; (B) Any chemical derivative of opium; or (C) Any synthetic or semisynthetic drug with opium-like effects. (c) “Opiate overdose” means a medical condition […]
Section 689.682 – Prescription of naloxone.
(1) In accordance with rules adopted by the State Board of Pharmacy under ORS 689.205, a pharmacist may prescribe naloxone and the necessary medical supplies to administer the naloxone. (2) If a prescription is presented to a pharmacist for dispensing an opiate or opioid in excess of a morphine equivalent dose established by rule by […]
Section 689.683
[2015 c.649 §2; 2015 c.649 §3; 2017 c.289 §§2,3; renumbered 689.689 in 2017]
Section 689.684 – Administration of naloxone by certain persons; rules.
(1) For purposes of this section, “social services agency” includes, but is not limited to, homeless shelters and crisis centers. (2) A person may administer to an individual naloxone that was not distributed to the person if: (a) The individual to whom the naloxone is being administered appears to be experiencing an opiate overdose as […]
Section 689.686 – Notice of availability of naloxone; rules.
(1) A retail or hospital outpatient pharmacy shall provide written notice in a conspicuous manner that naloxone and the necessary medical supplies to administer naloxone are available at the pharmacy. (2) The State Board of Pharmacy may adopt rules to carry out this section. [2019 c.470 §2]
Section 689.689 – Prescription and administration or dispensation of certain contraceptives; rules; insurance coverage.
(1) In accordance with rules adopted by the State Board of Pharmacy under ORS 689.205, a pharmacist may prescribe and administer injectable hormonal contraceptives and prescribe and dispense self-administered hormonal contraceptives. (2)(a) The board shall adopt rules to establish, in consultation with the Oregon Medical Board, the Oregon State Board of Nursing and the Oregon […]